Victrex plc (BST:1OY)
Germany · Delayed Price · Currency is EUR | Market Cap | 598.26M -31.1% |
| Revenue (ttm) | 336.59M -1.2% |
| Net Income | -22.56M |
| EPS | -0.26 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 15.06 |
| Dividend | 0.69 (11.08%) |
| Ex-Dividend Date | Jan 29, 2026 |
| Volume | n/a |
| Average Volume | 40 |
| Open | 6.45 |
| Previous Close | 6.50 |
| Day's Range | 6.45 - 6.90 |
| 52-Week Range | 5.65 - 9.90 |
| Beta | n/a |
| RSI | 48.51 |
| Earnings Date | May 11, 2026 |
About Victrex
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; and sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, aerospace, automotive, and electronics markets, as well as engages in trading activities. It serves automot... [Read more]
Financial Performance
In fiscal year 2025, Victrex's revenue was 292.70 million, an increase of 0.58% compared to the previous year's 291.00 million. Earnings were 27.80 million, an increase of 61.63%.
Financial numbers in GBP Financial StatementsNews
Victrex H1 Earnings Call Highlights
Victrex LON: VCT reported a modest increase in first-half revenue but lower profitability, as a weak first quarter, pricing pressure and adverse mix weighed on margins. Chief Executive Dr. James Routh...
Victrex price target lowered to 625 GBp from 725 GBp at JPMorgan
JPMorgan lowered the firm’s price target on Victrex (VTXPF) to 625 GBp from 725 GBp and keeps a Neutral rating on the shares.
Victrex price target lowered to 695 GBp from 880 GBp at Berenberg
Berenberg analyst Aron Ceccarelli lowered the firm’s price target on Victrex (VTXPF) to 695 GBp from 880 GBp and keeps a Hold rating on the shares.
Victrex price target lowered to 700 GBp from 740 GBp at Citi
Citi lowered the firm’s price target on Victrex (VTXPF) to 700 GBp from 740 GBp and keeps a Neutral rating on the shares.
Victrex price target lowered to 780 GBp from 850 GBp at Deutsche Bank
Deutsche Bank lowered the firm’s price target on Victrex (VTXPF) to 780 GBp from 850 GBp and keeps a Hold rating on the shares.
Invibio, Part of Victrex plc, Announces New Collaboration With Paragon Medical to Support Scale Up of PEEK Based Trauma Devices
LANCASTER, England--(BUSINESS WIRE)--Invibio establishes composite trauma manufacturing capacity in China, by collaborating with Paragon Medical.
Victrex Has Growth and Value
Victrex PLC ( LSE:VCT , Financial) is a British specialty chemicals company that is a world leader in high-performance polymer solutions.